Daniel Sundheim’s Pfizer PFE Stock Holding History

Daniel Sundheim’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,621,000	Closed	-$213M	–	40
2024 Q2	$213M	Sell	7,621,000 -209,000	-3%	-$5.75M	3.6%	11
2024 Q1	$217M	Buy	+7,830,000	New	+$217M	3.3%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Daniel Sundheim's PFE Position: Q3 2024 in Review

Daniel Sundheim sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,621,000 shares — an estimated $213M sold.

Daniel Sundheim first reported a position in PFE in Q1 2024 and held it in 2 quarters. The position peaked at $217M in Q1 2024. 2,913 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Daniel Sundheim reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Daniel Sundheim sold 7,621,000 Pfizer shares in Q3 2024, an estimated $213M.
Daniel Sundheim first reported a position in Pfizer in Q1 2024 and held it in 2 quarters.
Daniel Sundheim's Pfizer position peaked at $217M in Q1 2024.
2,913 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on D1 Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.